The latest quarterly R&D expense is $109.33 Million with a QoQ Growth of +10.57%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $109.33M.
$109.33M
$109.33 Million
Q2 FY2026 · 2026-06-30
+10.57%
vs. $98.88M prior quarter
18
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $109.33M | +10.57% | +25.26% |
| Q1 FY2026Period end 2026-03-31 | $98.88M | +0.66% | +12.88% |
| Q4 FY2025Period end 2025-12-31 | $98.23M | +8.31% | +13.13% |
| Q3 FY2025Period end 2025-09-30 | $90.70M | +3.91% | -4.33% |
| Q2 FY2025Period end 2025-06-30 | $87.29M | -0.36% | -0.97% |
| Q1 FY2025Period end 2025-03-31 | $87.60M | +0.89% | +25.87% |
| Q4 FY2024Period end 2024-12-31 | $86.83M | -8.41% | +25.92% |
| Q3 FY2024Period end 2024-09-30 | $94.81M | +7.56% | +56.21% |
| Q2 FY2024Period end 2024-06-30 | $88.14M | +26.65% | +44.46% |
| Q1 FY2024Period end 2024-03-31 | $69.60M | +0.93% | +18.51% |
| Q4 FY2023Period end 2023-12-31 | $68.96M | +13.62% | +25.42% |
| Q3 FY2023Period end 2023-09-30 | $60.69M | -0.53% | +12.46% |
| Q2 FY2023Period end 2023-06-30 | $61.01M | +3.90% | +12.96% |
| Q1 FY2023Period end 2023-03-31 | $58.73M | +6.81% | +13.00% |
| Q4 FY2022Period end 2022-12-31 | $54.98M | +1.88% | N/A |
| Q3 FY2022Period end 2022-09-30 | $53.97M | -0.09% | N/A |
| Q2 FY2022Period end 2022-06-30 | $54.02M | +3.93% | N/A |
| Q1 FY2022Period end 2022-03-31 | $51.97M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
